China Pulmonary Thromboembolism Registry Study Network (CURES Network)
The China Pulmonary Thromboembolism Registry Study Network (CURES Network) was established in January 2009 by the National Assembly of Pulmonary Embolism and Pulmonary Vascular Research Group under the leadership of Chinese Thoracic Society as a large prospective multicenter registry across the country that highlighted future research directions on PE in China. That network now consists of nearly 100 hospitals nationwide and has conducted numerous randomized controlled trials and real-world studies of VTE within China leading to the publication of papers and national guidelines.
Since the publication of the DissolVE-2 study - Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism-2, the network are working to assess the effectiveness of a system-wide multifaceted quality improvement (QI) strategy on VTE prophylaxis improvement and thromboembolism reduction in clinical setting (CHIPS-VTE) as well as leading a national program with the support of the Chinese National Health Commission for prevention and management of pulmonary embolism and deep Venous thrombosis in China (China VTE Prevention Program) – a program that aims to help hospitals nationwide establish a system for VTE prevention and management by formulating strategies of thromboprophylaxis, and standardizing the prevention, diagnosis and treatment of VTE.in China VTE Prevention Program.
Council Members
Chen Wang, MD
Professor of Respiratory Disease and Critical Care Medicine, Vice President, Chinese Academy of Engineering; President, Chinese Academy of Medical Sciences & Peking Union Medical College, Professor of Internal Medicine (Respiratory Medicine), Capital Medical University Professor of Physiology, Institute of Basic Medical Research, Peking Union Medical College Director, National Clinical Research Center of Respiratory Diseases.
Yongjun Li , MD, PhD
Chief Physician and Professor of the Department of Vascular Surgery at Beijing Hospital, National Center of Gerontology; Institute of Geriatric, Chinese Academy of Medical Sciences Doctoral Mentor of Beijing University of Medical Center; Peking Union Medical College.
Dr. Yongjun Li is committed to the diagnosis and treatment of peripheral vascular diseases and associated scientific research for more than 30 years. He has accumulated a wealth of clinical experience in the areas of Takayasu arteritis, atherosclerosis occlusion diseases, diabetic foot, aortic aneurysm, and venous disease - especially in venous thromboembolic diseases. Very skillful on interventional radiology therapy and open surgery.
Dr. Yongjun Li has served as Chairman of the Committee on Peripheral Vascular Diseases of the Chinese Medical Education Association, as a member of the Vascular Surgery of the Chinese Medical Association, and a member of the Committee of Vascular Surgeons of the Chinese Physicians Association. He has also served as an associated editor of Annal of Vascular Surgery and editorial board of other journals, such as Chinese Journal of Cardiovascular Medicine, the Chinese Journal of Vascular Surgery, the Chinese Journal of General Foundation and Clinical Research, and the Chinese Medical Journal.
Dr. Yongjun Li was awarded the third prize of the China Huaxia Medical Science and Technology Award, the third prize of the Chinese Medical Science and Technology Award, and other provincial and ministerial awards;. He was also awarded the "Outstanding Contribution Award" for Thrombosis Prevention and Control in China.
Dr. Yongjun Li currently manages the National Natural Science Foundation of China, participates in many national key research and development programs, and has published many articles.
Subscribe